Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

被引:34
|
作者
Chavda, Vivek P. [1 ]
Apostolopoulos, Vasso [2 ,3 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380008, Gujarat, India
[2] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic 3030, Australia
[3] Australian Inst Musculoskeletal Sci AIMSS, Immunol Program, Melbourne, Vic 3021, Australia
关键词
Omicron variant; SARS-CoV-2; booster dose; vaccine;
D O I
10.3390/vaccines10030367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Yuehong Hu
    Qiu Sun
    [J]. Signal Transduction and Targeted Therapy, 7
  • [32] Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
    Campos, Guilherme R. F.
    Almeida, Nathalie Bonatti Franco
    Filgueiras, Priscilla Soares
    Corsini, Camila Amormino
    Gomes, Sarah Vieira Contin
    de Miranda, Daniel Alvim Pena
    de Assis, Jessica Vieira
    Silva, Thais Barbara de Souza
    Alves, Pedro Augusto
    Fernandes, Gabriel da Rocha
    de Oliveira, Jaquelline Germano
    Rahal, Paula
    Grenfell, Rafaella Fortini Queiroz
    Nogueira, Mauricio L.
    [J]. COMMUNICATIONS MEDICINE, 2022, 2 (01):
  • [33] Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
    Guilherme R. F. Campos
    Nathalie Bonatti Franco Almeida
    Priscilla Soares Filgueiras
    Camila Amormino Corsini
    Sarah Vieira Contin Gomes
    Daniel Alvim Pena de Miranda
    Jéssica Vieira de Assis
    Thaís Bárbara de Souza Silva
    Pedro Augusto Alves
    Gabriel da Rocha Fernandes
    Jaquelline Germano de Oliveira
    Paula Rahal
    Rafaella Fortini Queiroz Grenfell
    Maurício L. Nogueira
    [J]. Communications Medicine, 2
  • [34] Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
    Mulgaonkar, Nirmitee
    Wang, Haoqi
    Zhang, Junrui
    Roundy, Christopher M.
    Tang, Wendy
    Chaki, Sankar Prasad
    Pauvolid-Correa, Alex
    Hamer, Gabriel L.
    Fernando, Sandun
    [J]. PHARMACEUTICS, 2023, 15 (07)
  • [35] Household transmission of the SARS-CoV-2 Omicron variant in Denmark
    Lyngse, Frederik Plesner
    Mortensen, Laust Hvas
    Denwood, Matthew J.
    Christiansen, Lasse Engbo
    Moller, Camilla Holten
    Skov, Robert Leo
    Spiess, Katja
    Fomsgaard, Anders
    Lassauniere, Ria
    Rasmussen, Morten
    Stegger, Marc
    Nielsen, Claus
    Sieber, Raphael Niklaus
    Cohen, Arieh Sierra
    Moller, Frederik Trier
    Overvad, Maria
    Molbak, Kare
    Krause, Tyra Grove
    Kirkeby, Carsten Thure
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [36] Audio Interview: Understanding the Omicron Variant of SARS-CoV-2
    Rubin, Eric J.
    Baden, Lindsey R.
    Morrissey, Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08): : E27 - E27
  • [37] Importation of SARS-CoV-2 Omicron variant in Beijing, China
    Li, Fu
    Liang, Zhichao
    Cui, Shujuan
    Lv, Bing
    Feng, Zhaomin
    Xu, Hui
    Jia, Lei
    Yang, Peng
    Wang, Quanyi
    Pan, Yang
    Zhang, Daitao
    [J]. BIOSAFETY AND HEALTH, 2022, 4 (03) : 150 - 153
  • [38] SARS-CoV-2 omicron variant: the black swan of microbiology
    Cheng, Zhangkai J.
    Xue, Mingshan
    Chen, Youpeng
    Zhang, Yong
    Sun, Baoqing
    [J]. ARCHIVES OF MICROBIOLOGY, 2022, 204 (10)
  • [39] Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
    Suzuki, Rigel
    Yamasoba, Daichi
    Kimura, Izumi
    Wang, Lei
    Kishimoto, Mai
    Ito, Jumpei
    Morioka, Yuhei
    Nao, Naganori
    Nasser, Hesham
    Uriu, Keiya
    Kosugi, Yusuke
    Tsuda, Masumi
    Orba, Yasuko
    Sasaki, Michihito
    Shimizu, Ryo
    Kawabata, Ryoko
    Yoshimatsu, Kumiko
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Sawa, Hirofumi
    Ikeda, Terumasa
    Irie, Takashi
    Matsuno, Keita
    Tanaka, Shinya
    Fukuhara, Takasuke
    Sato, Kei
    [J]. NATURE, 2022, 603 (7902) : 700 - +
  • [40] Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins
    Yang, Qiangzhen
    Syed, Ali Alamdar Shah
    Fahira, Aamir
    Shi, Yongyong
    [J]. RESEARCH, 2021, 2021